Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

NCT05714085 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

342

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure
Left Ventricular Systolic Dysfunction

Interventions

DRUG: Vericiguat tablet
DRUG: Vericiguat suspension
DRUG: Placebo tablet
DRUG: Placebo suspension

Sponsor

Merck Sharp & Dohme LLC